Skip to main content
Screener/Healthcare/Biotechnology

INBX — Inhibrx Biosciences, Inc.

NASDAQ
$113.85+29.73 (+35.37%)
Small CapHealthcareHigh Beta
$10.84
$155.29
$100.00
$155.29
EPS (TTM)$-9.04
P/E Ratio—
Dividend Yield1.33%
Market Cap$930.8M
Volume2.57M
Prev Close$84.08
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$32.8M$-2.11——
Q3 '25$0-$35.3M$-2.28——
Q2 '25$1.3M-$28.7M$-1.8549.1%-2204.2%
Q1 '25$0-$43.3M$-2.80——
Q4 '24$100K-$47.9M$-3.31-589.0%-47865.0%
Q3 '24$0-$43.9M$-2.84——
Q2 '24$100K$1.9B$125.48100.0%1858011.0%
Q1 '24$0-$78.7M$-1.44——
Get Your Daily Market Recap